|
|||||
|
|
Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases |
|
| Authors: | María Concepción López-Carrizosa Pilar María Samper-Ots Aurora Rodríguez Pérez |
| Affiliation: | (1) Department of Odontostomatology and Maxillo-Facial Surgery, University of Siena, Siena, Italy;(2) Department of Medical Oncology, University of Siena, Viale Bracci, 53100 Siena, Italy;(3) Department of Thoracic Surgery, University of Siena, Siena, Italy;(4) Pharmacology Unit, University of Siena, Siena, Italy |
| Abstract: | IntroductionWe evaluated serum C-telopeptides (CTX) to see whether they may be useful as predictive markers for disease progression in cancer patients with bone metastases who are being treated with zoledronic acid (ZA). |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |